Latest Cannabinoid receptor type 1 Stories
March springs forth and Publius celebrates the human body’s endo-healing power with four homeostatic updates from the National Institutes of Health (PubMed).
Colorectal (colon) cancer awareness and one’s cannabinoid system are the focus of this month’s health update from Publius and The Cannabis Papers: A citizen’s guide to cannabinoids (2011).
Scientists, publishing a paper in the journal Nature Neuroscience, say that the type 1 cannabinoid receptor in the olfactory bulb in the brain could be causing you to eat more at the smell of food.
In the 2011 chapter, “Sporting Cannabinoids,” the authors of The Cannabis Papers noted how exercise is cannabinoid dependent.
New research published in the Proceedings of the National Academy of Sciences Early Edition this week has identified a cellular change in the brain that has been linked to obesity.
A research team from Inserm has published a new study in the journal Biological Psychology detailing the key role played by a protein, the CB1 cannabinoid receptor, during physical exercise.
A second-generation experimental anti-obesity and diabetes drug has shown promise in reducing body weight in rodents just as effectively as the predecessor rimonabant while avoiding the risk of psychiatric side effects that led to the withdrawal of rimonabant from the market and stopped further development of other brain-penetrating drugs of its type.
- Of or relating to good digestion.